Similar articles for PMID: 28976149

Year	Number of Results
1989	1
1992	1
2001	1
2002	1
2004	1
2005	2
2006	4
2007	4
2008	6
2009	1
2010	2
2011	3
2013	3
2014	4
2015	3
2016	2
2017	1
2020	1
2024	0

1

[Intronic polymorphisms of аntionkogene TP53 in patients with indolent variants of Non-Hodgkin's lymphomas].

Voropaeva EN, Voevoda MI, Pospelova TI, Мaksimov VN. Voropaeva EN, et al. Adv Gerontol. 2013;26(2):258-262. Adv Gerontol. 2013. PMID: 28976149 Russian.

2

TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.

Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, Kumar G, Singh M, Mahapatra AK, Sarkar C. Jha P, et al. Exp Mol Pathol. 2011 Apr;90(2):167-72. doi: 10.1016/j.yexmp.2010.11.002. Epub 2010 Nov 27. Exp Mol Pathol. 2011. PMID: 21115003

3

Metabolic gene variants and risk of non-Hodgkin's lymphoma.

De Roos AJ, Gold LS, Wang S, Hartge P, Cerhan JR, Cozen W, Yeager M, Chanock S, Rothman N, Severson RK. De Roos AJ, et al. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1647-53. doi: 10.1158/1055-9965.EPI-06-0193. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16985026

4

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.

Soucek P, Sarmanová J, Kristensen VN, Apltauerová M, Gut I. Soucek P, et al. Int Arch Occup Environ Health. 2002 Oct;75 Suppl:S86-92. doi: 10.1007/s00420-002-0353-1. Epub 2002 Jul 3. Int Arch Occup Environ Health. 2002. PMID: 12397416

5

Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.

Heinze B, Herrmann LJ, Fassnacht M, Ronchi CL, Willenberg HS, Quinkler M, Reisch N, Zink M, Allolio B, Hahner S. Heinze B, et al. Eur J Endocrinol. 2014 Apr 10;170(5):707-17. doi: 10.1530/EJE-13-0788. Print 2014 May. Eur J Endocrinol. 2014. PMID: 24566897

6

Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants.

Deben C, Van den Bossche J, Van Der Steen N, Lardon F, Wouters A, de Beeck KO, Hermans C, Jacobs J, Peeters M, Van Camp G, Rolfo C, Deschoolmeester V, Pauwels P. Deben C, et al. Tumour Biol. 2017 Feb;39(2):1010428317694327. doi: 10.1177/1010428317694327. Tumour Biol. 2017. PMID: 28240049 Free article.

7

[Linkage disequilibrium and haplotypes of rs1042522, rs1625895 and rs17878362 gene TP53 markers in patients with diffuse large B-cell lymphoma].

Voropaeva EN, Voevoda MI, Pospelova TI, Maksimov VN. Voropaeva EN, et al. Mol Biol (Mosk). 2014 Sep-Oct;48(5):763-70. Mol Biol (Mosk). 2014. PMID: 25842861 Free article. Russian.

8

Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India.

Surekha D, Sailaja K, Rao DN, Padma T, Raghunadharao D, Vishnupriya S. Surekha D, et al. Asian Pac J Cancer Prev. 2011;12(8):1893-8. Asian Pac J Cancer Prev. 2011. PMID: 22292621 Free article.

9

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.

Diepstra A, Niens M, Vellenga E, van Imhoff GW, Nolte IM, Schaapveld M, van der Steege G, van den Berg A, Kibbelaar RE, te Meerman GJ, Poppema S. Diepstra A, et al. Lancet. 2005 Jun 25-Jul 1;365(9478):2216-24. doi: 10.1016/S0140-6736(05)66780-3. Lancet. 2005. PMID: 15978930

10

Cytokine gene polymorphisms in Egyptian cases with brain tumors.

Settin A, Ali N, Salem FK. Settin A, et al. Egypt J Immunol. 2008;15(2):15-23. Egypt J Immunol. 2008. PMID: 20306684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year